Your browser doesn't support javascript.
loading
Brain structural correlates of insomnia severity in 1053 individuals with major depressive disorder: results from the ENIGMA MDD Working Group.
Leerssen, Jeanne; Blanken, Tessa F; Pozzi, Elena; Jahanshad, Neda; Aftanas, Lyubomir; Andreassen, Ole A; Baune, Bernhard T; Brack, Ivan; Carballedo, Angela; Ching, Christopher R K; Dannlowski, Udo; Dohm, Katharina; Enneking, Verena; Filimonova, Elena; Fingas, Stella M; Frodl, Thomas; Godlewska, Beata R; Goltermann, Janik; Gotlib, Ian H; Grotegerd, Dominik; Gruber, Oliver; Harris, Mathew A; Hatton, Sean N; Hawkins, Emma; Hickie, Ian B; Jaworska, Natalia; Kircher, Tilo; Krug, Axel; Lagopoulos, Jim; Lemke, Hannah; Li, Meng; MacMaster, Frank P; McIntosh, Andrew M; McLellan, Quinn; Meinert, Susanne; Mwangi, Benson; Nenadic, Igor; Osipov, Evgeny; Portella, Maria J; Redlich, Ronny; Repple, Jonathan; Sacchet, Matthew D; Sämann, Philipp G; Simulionyte, Egle; Soares, Jair C; Walter, Martin; Watanabe, Norio; Whalley, Heather C; Yüksel, Dilara; Veltman, Dick J.
Afiliação
  • Leerssen J; Department of Sleep and Cognition, Netherlands Institute for Neuroscience, an Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam, The Netherlands. j.leerssen@vu.nl.
  • Blanken TF; Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam, Amsterdam, The Netherlands. j.leerssen@vu.nl.
  • Pozzi E; Department of Sleep and Cognition, Netherlands Institute for Neuroscience, an Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam, The Netherlands.
  • Jahanshad N; Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam, Amsterdam, The Netherlands.
  • Aftanas L; Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Melbourne, VIC, Australia.
  • Andreassen OA; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia.
  • Baune BT; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Marina del Rey, CA, USA.
  • Brack I; Department of Clinical Neuroscience, Behavior & Neurotechnology, Scientific Research Institute of Neuroscience & Medicine, Novosibirsk, Russia.
  • Carballedo A; Department of Neuroscience, Novosibirsk State University, Novosibirsk, Russia.
  • Ching CRK; NORMENT Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Dannlowski U; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Dohm K; Department of Psychiatry, Melbourne Medical School, University of Melbourne, Parkville, VIC, Australia.
  • Enneking V; Department of Psychiatry, University of Münster, Münster, Germany.
  • Filimonova E; Department of Clinical Neuroscience, Behavior & Neurotechnology, Scientific Research Institute of Neuroscience & Medicine, Novosibirsk, Russia.
  • Fingas SM; Department of Psychiatry, Trinity College Dublin, Dublin, Ireland.
  • Frodl T; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Marina del Rey, CA, USA.
  • Godlewska BR; Department of Psychiatry, University of Münster, Münster, Germany.
  • Goltermann J; Department of Psychiatry, University of Münster, Münster, Germany.
  • Gotlib IH; Department of Psychiatry, University of Münster, Münster, Germany.
  • Grotegerd D; Department of Clinical Neuroscience, Behavior & Neurotechnology, Scientific Research Institute of Neuroscience & Medicine, Novosibirsk, Russia.
  • Gruber O; Department of Psychiatry, University of Münster, Münster, Germany.
  • Harris MA; Department of Psychiatry, Trinity College Dublin, Dublin, Ireland.
  • Hatton SN; Department of Psychiatry and Psychotherapy, Otto von Guericke University Magdeburg, Magdeburg, Germany.
  • Hawkins E; Psychopharmacology Research Unit, Department of Psychiatry, University of Oxford, Oxford, UK.
  • Hickie IB; Department of Psychiatry, University of Münster, Münster, Germany.
  • Jaworska N; Department of Psychology, Stanford University, Stanford, CA, USA.
  • Kircher T; Department of Psychiatry, University of Münster, Münster, Germany.
  • Krug A; Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Germany.
  • Lagopoulos J; Division of Psychiatry, University of Edinburgh, Edinburgh, UK.
  • Lemke H; Youth Mental Health Team, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.
  • Li M; Division of Psychiatry, University of Edinburgh, Edinburgh, UK.
  • MacMaster FP; Youth Mental Health Team, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.
  • McIntosh AM; University of Ottawa's Institute of Mental Health Research, Ottawa, ON, Canada.
  • McLellan Q; Cellular & Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.
  • Meinert S; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Mwangi B; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Nenadic I; Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany.
  • Osipov E; Sunshine Coast Mind and Neuroscience Thompson Institute, Birtinya, QLD, Australia.
  • Portella MJ; Department of Psychiatry, University of Münster, Münster, Germany.
  • Redlich R; Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.
  • Repple J; Max Planck Institute for Biological Cybernetics, Tübingen, Germany.
  • Sacchet MD; Psychiatry and Paediatrics, University of Calgary, Calgary, AB, Canada.
  • Sämann PG; Strategic Clinical Network for Addictions and Mental Health, Calgary, AB, Canada.
  • Simulionyte E; Division of Psychiatry, University of Edinburgh, Edinburgh, UK.
  • Soares JC; Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.
  • Walter M; Psychiatry and Paediatrics, University of Calgary, Calgary, AB, Canada.
  • Watanabe N; Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
  • Whalley HC; Department of Psychiatry, University of Münster, Münster, Germany.
  • Yüksel D; Department of Psychiatry, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Veltman DJ; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
Transl Psychiatry ; 10(1): 425, 2020 12 08.
Article em En | MEDLINE | ID: mdl-33293520
ABSTRACT
It has been difficult to find robust brain structural correlates of the overall severity of major depressive disorder (MDD). We hypothesized that specific symptoms may better reveal correlates and investigated this for the severity of insomnia, both a key symptom and a modifiable major risk factor of MDD. Cortical thickness, surface area and subcortical volumes were assessed from T1-weighted brain magnetic resonance imaging (MRI) scans of 1053 MDD patients (age range 13-79 years) from 15 cohorts within the ENIGMA MDD Working Group. Insomnia severity was measured by summing the insomnia items of the Hamilton Depression Rating Scale (HDRS). Symptom specificity was evaluated with correlates of overall depression severity. Disease specificity was evaluated in two independent samples comprising 2108 healthy controls, and in 260 clinical controls with bipolar disorder. Results showed that MDD patients with more severe insomnia had a smaller cortical surface area, mostly driven by the right insula, left inferior frontal gyrus pars triangularis, left frontal pole, right superior parietal cortex, right medial orbitofrontal cortex, and right supramarginal gyrus. Associations were specific for insomnia severity, and were not found for overall depression severity. Associations were also specific to MDD; healthy controls and clinical controls showed differential insomnia severity association profiles. The findings indicate that MDD patients with more severe insomnia show smaller surfaces in several frontoparietal cortical areas. While explained variance remains small, symptom-specific associations could bring us closer to clues on underlying biological phenomena of MDD.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior / Distúrbios do Início e da Manutenção do Sono Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior / Distúrbios do Início e da Manutenção do Sono Idioma: En Ano de publicação: 2020 Tipo de documento: Article